K192133 is an FDA 510(k) clearance for the Zimmer Biomet Universal Navigation System. Classified as Orthopedic Stereotaxic Instrument within the OLO classification (a category covering orthopedic stereotaxic and surgical navigation instruments), Class II - Special Controls.
Submitted by Zimmer Biomet Spine, Inc. (Westminister, US). The FDA issued a Cleared decision on October 29, 2019 after a review of 83 days - a notably fast clearance cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 882.4560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Zimmer Biomet Spine, Inc. devices